Melrilimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Melrilimab, covering 2021-11-05 to 2021-11-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Melrilimab (GSK3772847) in Healthy Participants [Phase 1]